ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ibritumomab tiuxetan, covering 2012-04-03 to 2018-07-13. Get the full timeline:
Most recent: Clinical Trial Update: Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance [Phase 2]